Rallybio CFO Jonathan Lieber to Transition to Part-Time and Depart Upon Merger Closing

Filing content

Rallybio CFO Jonathan Lieber will transition to part-time status effective September 15, 2026, and his employment will terminate upon the closing of the merger with Avenzo Therapeutics.